Literature DB >> 21930957

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Chung Yin Kong1, Kevin J Nattinger, Tristan J Hayeck, Zehra B Omer, Y Claire Wang, Stuart J Spechler, Pamela M McMahon, G Scott Gazelle, Chin Hur.   

Abstract

BACKGROUND: The United States has experienced an alarming and unexplained increase in the incidence of esophageal adenocarcinoma (EAC) since the 1970s. A concurrent increase in obesity has led some to suggest a relationship between the two trends. We explore the extent of this relationship.
METHODS: Using a previously validated disease simulation model of white males in the United States, we estimated EAC incidence 1973 to 2005 given constant obesity prevalence and low population progression rates consistent with the early 1970s. Introducing only the observed, rising obesity prevalence, we calculated the incremental incidence caused by obesity. We compared these with EAC incidence data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registry to determine obesity's contribution to the rise therein. Incidences were converted to absolute numbers of cases using U.S. population data.
RESULTS: Using constant obesity prevalence, we projected a total of 30,555 EAC cases cumulatively over 1973 to 2005 and 1,151 in 2005 alone. Incorporating the observed obesity trend resulted in 35,767 cumulative EACs and 1,608 in 2005. Estimates derived from SEER data showed 111,223 cumulative and 7,173 cases in 2005. We conclude that the rise in obesity accounted for 6.5% of the increase in EAC cases that occurred from 1973 to 2005 and 7.6% in the year 2005.
CONCLUSION: Using published OR for EAC among obese individuals, we found that only a small percentage of the rise in EAC incidence is attributable to secular trends in obesity. IMPACT: Other factors, alone and in combination, should be explored as causes of the EAC epidemic.
© 2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21930957      PMCID: PMC3382986          DOI: 10.1158/1055-9965.EPI-11-0547

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  60 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

Review 2.  Time trends of gastroesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12-04       Impact factor: 11.382

3.  Central adiposity and risk of Barrett's esophagus.

Authors:  Zoe R Edelstein; Diana C Farrow; Mary P Bronner; Sheldon N Rosen; Thomas L Vaughan
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

4.  Body-mass index and symptoms of gastroesophageal reflux in women.

Authors:  Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

5.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

6.  Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States).

Authors:  Jihyoun Jeon; E Georg Luebeck; Suresh H Moolgavkar
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

7.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential.

Authors:  G W Clark; A P Ireland; J H Peters; P Chandrasoma; T R DeMeester; C G Bremner
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

9.  Forecasting the obesity epidemic in the aging U.S. population.

Authors:  Y Claire Wang; Graham A Colditz; Karen M Kuntz
Journal:  Obesity (Silver Spring)       Date:  2007-11       Impact factor: 5.002

10.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

View more
  18 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.

Authors:  Craig S Brown; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

3.  Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.

Authors:  Jennifer Drahos; Qian Xiao; Harvey A Risch; Neal D Freedman; Christian C Abnet; Lesley A Anderson; Leslie Bernstein; Linda Brown; Wong-Ho Chow; Marilie D Gammon; Farin Kamangar; Linda M Liao; Liam J Murray; Mary H Ward; Weimin Ye; Anna H Wu; Thomas L Vaughan; David C Whiteman; Michael B Cook
Journal:  Int J Cancer       Date:  2015-08-26       Impact factor: 7.396

4.  Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.

Authors:  Erik J Snider; Griselda Compres; Daniel E Freedberg; Hossein Khiabanian; Yael R Nobel; Stephania Stump; Anne-Catrin Uhlemann; Charles J Lightdale; Julian A Abrams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-29       Impact factor: 4.254

Review 5.  Nutrition therapy issues in esophageal cancer.

Authors:  Keith R Miller; Matthew C Bozeman
Journal:  Curr Gastroenterol Rep       Date:  2012-08

6.  Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients.

Authors:  Craig S Brown; Brittany Lapin; Chi Wang; Jay L Goldstein; John G Linn; Woody Denham; Stephen P Haggerty; Mark S Talamonti; John A Howington; Joann Carbray; Michael B Ujiki
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

Review 7.  Emerging Insights into the Esophageal Microbiome.

Authors:  Michael May; Julian A Abrams
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

Review 8.  Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.

Authors:  Aaron P Thrift
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-18       Impact factor: 46.802

Review 9.  Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Erik J Snider; Daniel E Freedberg; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

Review 10.  Imaging of Ventricular Fibrillation and Defibrillation: The Virtual Electrode Hypothesis.

Authors:  Bastiaan J Boukens; Sarah R Gutbrod; Igor R Efimov
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.